Výsledky vyhledávání - "Hiroyoshi KATO"

Akademický článek

Retrospective cohort study of the efficacy and safety of dabigatran: real-life dabigatran use including very low-dose 75 mg twice daily administration

Autor: Yuuki Akagi, Tatsuo Chiba, Shusuke Uekusa, Hiroyoshi Kato, Shigeo Yamamura, Yukiko Aoki, Mizuho Enoki, Yuka Ogawara, Takanori Kasahara, Yuki Kimura, Tadahiro Shimizu, Aiko Takeishi, Yuko Nakajima, Hideki Kobayashi, Kaoru Sugi

Publikováno v: Journal of Pharmaceutical Health Care and Sciences, Vol 5, Iss 1, Pp 1-7 (2019)

Abstract Background Dabigatran is a direct thrombin inhibitor and an anticoagulant that is prescribed to prevent ischemic stroke and systemic embolism in non-valvular atrial fibrillation. Dabigatran (150 mg twice daily) is non-inferior to warfarin fo

Externí odkaz: https://doaj.org/article/5b1cc2f2fc434a4e9054db4b3a2f39ce

Zobrazit plný text záznamu

Akademický článek

Characteristics of Ferrite-Rich Portland Cement: Comparison With Ordinary Portland Cement

Autor: Yogarajah Elakneswaran, Natsumi Noguchi, Kazuki Matumoto, Yuka Morinaga, Takashi Chabayashi, Hiroyoshi Kato, Toyoharu Nawa

Publikováno v: Frontiers in Materials, Vol 6 (2019)

The cement industry is an energy-intensive industry, and improving the energy efficiency of cement has become necessary to reduce its carbon footprint and to compete in the global market. Clinker production consumes more than 90% of the total energy

Externí odkaz: https://doaj.org/article/bfce1aa11bb1436ab1aecbd9d5d02da9

Zobrazit plný text záznamu

Good response to methotrexate is associated with a decrease in the gene expression of ABCG2, a drug transporter, in patients with rheumatoid arthritis

Autor: Arata Nakajima, Hiroyoshi Kato, Satoshi Muto, Sumiko Hiura, Takehisa Ogura, Hideki Kobayashi, Toru Masaka, Koichi Nakagawa, Nana Minamitani, Hideto Kameda

Publikováno v: Modern Rheumatology. 31:1079-1086

Objectives Methotrexate (MTX) is used as an anchor drug in the treatment of rheumatoid arthritis (RA), although more than a half of the patients with RA require additional treatments. We designed a prospective study involving two medical centers in J

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::471817b021f0e7e4caf666169a2bc02f
https://doi.org/10.1080/14397595.2021.1879429

Zobrazit plný text záznamu

Good response to methotrexate is associated with a decrease in the gene expression of the drug transporter ABCG2 in patients with rheumatoid arthritis

Autor: Satoshi Muto, Nana Minamitani, Takehisa Ogura, Arata Nakajima, Koichi Nakagawa, Toru Masaka, Sumiko Hiura, Hideki Kobayashi, Hiroyoshi Kato, Hideto Kameda

Background Methotrexate (MTX) is an anchor drug in the treatment of rheumatoid arthritis (RA). We previously performed a cross-sectional, observational study and reported an association between the gene expression level of the drug transporter ABCG2/

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a9e97a8ac7f2f5a4fe1cb5736bb48e84
https://doi.org/10.21203/rs.3.rs-28597/v1

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání